Clinical Trials Directory

Trials / Unknown

UnknownNCT04314973

PaDAWAn: Parkinson's Disease - Adaptive Walking Assistance

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
41 (estimated)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to develop and validate a haptic assistive method in order to support walking in patients with Parkinson's disease, delivered to the patient's hips through a wearable robotic pelvis orthosis.

Detailed description

None of the existing robotic devices used for gait rehabilitation in Parkinson's disease is wearable. Thanks to the wearable robotic pelvis orthosis we will use, the rehabilitation sessions can take place in an ecological environment. The other advantage of the proposed assistance protocol is its adaptability: patients will feel their hips pattern to be "smoothed" by the robot, but they will keep the freedom of continuously steering their main movement variables (like stride frequency, duration, and length). A key measured metric will precisely rely on this variability between stride durations. Indeed, the degree of stride-to-stride variability was shown to reflect the patient's physiological state, and to be correlated with the stage of the disease. Experimental trials will be conducted to assess both the assistive (i.e. the therapy effect during the therapy itself) and rehabilitative (i.e. effect after the therapy) natures of our protocol. The second main objective of this project will be the analysis of the effects of our protocol regarding the stride-to-stride variability of patients with Parkinson's disease.

Conditions

Interventions

TypeNameDescription
DEVICEActive Pelvis OrthosisWalking with the robotic device providing the assistive protocol.
OTHERWalking exercisesWalking exercises without wearing the robotic device.

Timeline

Start date
2022-01-27
Primary completion
2023-01-01
Completion
2023-06-01
First posted
2020-03-19
Last updated
2022-06-21

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04314973. Inclusion in this directory is not an endorsement.